Skip to content

Opening book details…

Can I read Efficacy and safety of selective serotonin re-uptake inhibitors for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis on EtoBox?

Efficacy and safety of selective serotonin re-uptake inhibitors for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis by Yongfeng Lao; Lijuan He; Peihao Zhang; Zhilong Dong is a Medicine article available to read on EtoBox.

What is Efficacy and safety of selective serotonin re-uptake inhibitors for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis about?

Table 1 Results of network meta-analysis. Bold refers to results of meta-analysis with statistical differences. \*Data was presented in MD combined with 95%CrI. # Data was presented in Log(OR) combined with 95%CrI. NIHeCPSI\* RD (SUCRA 1⁄4 8.43%) e e e e e e ¡3.12 (-4.85, -1.30) RD þ Dapoxetine (SUCRA 1⁄4 57.80%) e e e e e ¡2.51 (-4.96, -0.20) 0.61 (À2.48, 3.47) RD þ Fluoxetine (SUCRA 1⁄4 48.20%) e e e e ¡2.35 (-4.50, -0.19) 0.78 (À2.07, 3.50) 0.16 (À2.98, 3.45) RD þ Paroxetine (SUCRA 1⁄4 45.49) e e e ¡4.74 (-6.35, -2.93) À1.62 (À4.02, 0.87) À2.23 (À5.01, 0.89) À2.40 (À5.03, 0.46) RD þ Placebo (SUCRA 1⁄4 79.81%) e e ¡8.36 (-9.63, -7.04) ¡5.23 (-7.46, -3.07) ¡5.85 (-8.47, -3.03) ¡6.01 (-8.48, -3.47) ¡3.62 (-4.79, -2.60) RD þ Sertraline (SUCRA 1⁄4 99.99%) e À0.06 (À1.57, 1.55) 3.07 (0.70, 5.42) 2.45 (À0.28, 5.43) 2.29 (À0.32, 5.02) 4.68 (2.74, 6.53) 8.30 (6.77, 9.87) Sertraline (SUCRA 1⁄4 10.27%) Clinical effective rate # RD (SUCRA 1⁄4 18.63%) e e e e e e ¡1.77 (-2.89, -0.70) RD þ Dapoxetine (SUCRA 1⁄4 89.24%) e e e e e À0.55 (À1.45, 0.34) 1.23 (À0.20, 2.68) RD þ Fluoxetine (SUCRA 1⁄4 46.03%) e e e e ¡1.24 (-2.04, -0.49) 0.54 (À0.80, 1.87) À0.69 (À1.88, 0.48) RD þ Paroxetine (SUCRA 1

Who reads Efficacy and safety of selective serotonin re-uptake inhibitors for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Yongfeng Lao; Lijuan He; Peihao Zhang; Zhilong Dong
Publisher
Elsevier BV
Published
2022
Language
EN
Field
Medicine (Health Sciences)